Patel Chem Specialities

Patel Chem Specialities

87.00
+2.13
(2.51%)
hide
Key Fundamentals
Add Ratio
Market Cap
216.40 Cr
EPS
6.10
PE Ratio
19.97
Dividend Yield
0.00 %
Industry
-
52 Week High
120.89
52 Week Low
75.11
PB Ratio
2.24
Debt to Equity
0.55
Sector
-
Forecast For
Actual

Company News

View All News
Caret
positive
Patel Chem Specialities Limited reported revenue from operations of ₹6,115.81 lakhs for the half-year ended September 30, 2025, compared to ₹5,494.86 lakhs in the previous half-year, with net profit increasing to ₹612.92 lakhs from ₹534.11 lakhs. The pharmaceutical excipients and specialty chemicals manufacturer also corrected a typographical error in its earlier corporate announcement regarding the date of financial results disclosure.
positive
Patel Chem Specialities Reports 14.7% Revenue Growth in Half-Year Results2 days ago
Patel Chem Specialities Limited reported revenue from operations of ₹6,115.81 lakhs for the half-year ended September 30, 2025, compared to ₹5,494.86 lakhs in the previous period, with net profit rising to ₹612.92 lakhs from ₹534.11 lakhs. The pharmaceutical excipients and specialty chemicals manufacturer's Board approved these unaudited financial results on November 14, 2025, showing improved operational performance across key metrics.
positive
Patel Chem Specialities Limited executed an Independent Turnkey Project Service Agreement with J & H Pharma Consultants for their Indrad Plant, valued at Rs 45 crores. The consultant will design, engineer, procure, construct, and test the project before delivering it in fully operational condition to Patel Chem Specialities. The project is located at Mouje Village, Taluka Talod. J & H Pharma Consultants is not related to the promoter or promoter group of the company, and the transaction does not fall under related party transactions.
View more
Growth Rate
Revenue Growth
27.69 %
Net Income Growth
37.66 %
Cash Flow Change
-68.75 %
ROE
-23.87 %
ROCE
-19.05 %
EBITDA Margin (Avg.)
2.55 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
TTM
Revenue
43
61
70
83
106
0
Expenses
40
56
64
71
90
0
EBITDA
3
5
6
12
16
0
Operating Profit %
6 %
7 %
8 %
14 %
15 %
0 %
Depreciation
0
0
1
1
1
0
Interest
0
1
1
1
1
0
Profit Before Tax
2
4
4
10
14
0
Tax
0
1
1
3
4
0
Net Profit
1
2
3
8
11
0
EPS in ₹
13.20
1.34
1.70
4.50
6.10
0.00

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
18
24
37
47
65
Fixed Assets
6
10
14
14
14
Current Assets
11
13
23
27
39
Capital Work in Progress
0
0
0
3
12
Investments
0
0
0
0
0
Other Assets
13
13
24
31
39
Total Liabilities
18
24
37
47
65
Current Liabilities
9
11
19
20
22
Non Current Liabilities
3
4
6
7
8
Total Equity
7
9
12
20
35
Reserve & Surplus
6
8
11
19
18
Share Capital
1
1
1
1
18

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
-1,670
-1
-1
1
0
Investing Activities
-1,978
-4
-3
-6
-7
Operating Activities
-24
2
2
6
2
Financing Activities
332
0
1
0
5

Share Holding

% Holding
Dec 2024
Jun 2025
Jul 2025
Sept 2025
Promoter
95.13 %
68.36 %
68.36 %
68.36 %
FIIs
0.00 %
6.50 %
6.50 %
8.19 %
DIIs
0.00 %
6.83 %
6.83 %
1.81 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
16.74 %
16.74 %
13.43 %
Others
4.87 %
1.58 %
1.58 %
8.21 %
No of Share Holders
92
1,084
92
924

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 90.50 87.77

Announcements

Statement Of Deviation And Variation For Half Year Ended September 20252 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report2 days ago
Announcement Under Regulation 30 (LODR)2 days ago
Announcement Under Regulation 30 (LODR)- Change In Management2 days ago
Financial Result For Half Year Ended 30/09/20252 days ago
Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On Thursday November 6 20252 days ago
Board Meeting Intimation for Board Meeting Intimation For Consideration Of Un-Audited Financial Statement For The Half - Yearly Ended On September 302025.Nov 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Intimation Of Change In Email Address Of Registrar And Share Transfer Agent ("RTA") Of The CompanySep 30, 2025
Intimation Of Change In Email Address Of Registrar And Share Transfer Agent ("RTA") Of The CompanySep 30, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsSep 23, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsSep 22, 2025
Environmental Clearance (EC) Received For The Proposed Project At INDRAD PlantSep 05, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsAug 30, 2025
Intimation For Change Of Corporate Identification Number (CIN) Of The CompanyAug 30, 2025
Intimation Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligation And Disclosures Requirements) Regulation 2015Aug 01, 2025
Announcement Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligation And Disclosures Requirements) Regulation 2015Aug 01, 2025
Listing Of Equity Shares Of Patel Chem Specialities LimitedAug 01, 2025
Listing of Equity Shares of Patel Chem Specialities LtdAug 01, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
WhiteOak Capital Equity Savings Fund Direct - Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
29.68
ATR(14)
Volatile
4.51
STOCH(9,6)
Neutral
45.89
STOCH RSI(14)
Neutral
33.33
MACD(12,26)
Bearish
-0.22
ADX(14)
Weak Trend
16.46
UO(9)
Bearish
49.22
ROC(12)
Downtrend And Accelerating
-6.62
WillR(14)
Neutral
-49.66